BioSpace News Archive

Ocular Therapeutix, Inc. today announced the receipt of a warning letter from the U.S. Food and Drug Administration (FDA) dated October 17, 2018 and received on October 18, 2018.

Middlefield Healthcare & Life Sciences Dividend Fund is pleased to announce that distributions for the fourth quarter of 2018 will be payable to unitholders of Middlefield Healthcare & Life Sciences Dividend Fund as follows

Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant.

MSI-High Status Now Part of Guardant360® Assay

Product innovations with recent approvals across Baxter’s Acute Therapies, Clinical Nutrition and Medication Delivery businesses to be featured

Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the initial phase II study of MIV-711, which demonstrated disease-modifying activity in patients with moderate knee osteoarthritis after only six months of treatment, will be presented during the American College of Rheumatology (ACR) annual meeting

The American Society for Aesthetic Plastic Surgery (ASAPS/The Aesthetic Society) is hosting its Experienced Insights: Breast and Body Contouring meeting in San Francisco this week from October 18 through October 20 at the InterContinental Mark Hopkins hotel in San Francisco.

According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023 while growing at a CAGR of 37% during the forecast period

At the three-year mark, patients receiving TREMFYA® in clinical studies continue to show stably maintained PASI 90 and IGA 0/1 responses

At this year’s American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, October 21-24, 2018 (Booth #3737), Canon Medical Systems USA, Inc. will showcase its recently FDA-cleared Aquilion PrecisionTM